FIELD: medicine. SUBSTANCE: method involves introducing sorption drain tampon in intrauterine mode. The tampon is produced from capron membrane having dialysis pores of 1.5-3.0 nm filled with carbon mineral sorbent agent with Metronidasolum absorbed in it at a dose of 3 mg/ml. EFFECT: enhanced effectiveness of inflammation process treatment; accelerated inhibition of microflora development. 6 tbl
Authors
Dates
1998-11-20—Published
1995-07-31—Filed